Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance

Francesco Perna; A Zullo; C Ricci; Cesare Hassan; S Morini; D. Vaira

doi:10.1016/j.dld.2007.06.016

Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance

Francesco Perna, A Zullo, C Ricci, Cesare Hassan, S Morini, D. Vaira

Risultato della ricerca: Contributo in rivista › Articolo in rivista

92 Citazioni (Scopus)

Abstract

First-line Helicobacter pylori therapy fails in more than 20% of patients. Quadruple therapy is the suggested second-line therapy, but bismuth salts are not anymore available worldwide. This study aimed to assess the efficacy of a levofloxacin-amoxycillin triple therapy as a second-line treatment, and the role of primary levofloxacin resistance.

Lingua originale	English
pagine (da-a)	1001-1005
Numero di pagine	5
Rivista	Digestive and Liver Disease
Volume	39
DOI	https://doi.org/10.1016/j.dld.2007.06.016
Stato di pubblicazione	Pubblicato - 2007
Pubblicato esternamente	Sì

Keywords

2-Pyridinylmethylsulfinylbenzimidazoles
Adult
Amoxicillin
Anti-Bacterial Agents
Breath Tests
Drug Resistance, Bacterial
Drug Therapy, Combination
Female
Helicobacter Infections
Humans
Male
Middle Aged
Ofloxacin
Prospective Studies
Proton Pump Inhibitors
Retreatment

Accesso al documento

10.1016/j.dld.2007.06.016

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{c437b48c010d4ca68753c19be4322c89,

title = "Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance",

abstract = "First-line Helicobacter pylori therapy fails in more than 20% of patients. Quadruple therapy is the suggested second-line therapy, but bismuth salts are not anymore available worldwide. This study aimed to assess the efficacy of a levofloxacin-amoxycillin triple therapy as a second-line treatment, and the role of primary levofloxacin resistance.",

keywords = "2-Pyridinylmethylsulfinylbenzimidazoles, Adult, Amoxicillin, Anti-Bacterial Agents, Breath Tests, Drug Resistance, Bacterial, Drug Therapy, Combination, Female, Helicobacter Infections, Humans, Male, Middle Aged, Ofloxacin, Prospective Studies, Proton Pump Inhibitors, Retreatment, 2-Pyridinylmethylsulfinylbenzimidazoles, Adult, Amoxicillin, Anti-Bacterial Agents, Breath Tests, Drug Resistance, Bacterial, Drug Therapy, Combination, Female, Helicobacter Infections, Humans, Male, Middle Aged, Ofloxacin, Prospective Studies, Proton Pump Inhibitors, Retreatment",

author = "Francesco Perna and A Zullo and C Ricci and Cesare Hassan and S Morini and D. Vaira",

year = "2007",

doi = "10.1016/j.dld.2007.06.016",

language = "English",

volume = "39",

pages = "1001--1005",

journal = "Digestive and Liver Disease",

issn = "1590-8658",

publisher = "-Roma: Editrice Gastroenterologica Italiana. -Ospedaletto Pisa: Pacini",

}

TY - JOUR

T1 - Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance

AU - Perna, Francesco

AU - Zullo, A

AU - Ricci, C

AU - Hassan, Cesare

AU - Morini, S

AU - Vaira, D.

PY - 2007

Y1 - 2007

N2 - First-line Helicobacter pylori therapy fails in more than 20% of patients. Quadruple therapy is the suggested second-line therapy, but bismuth salts are not anymore available worldwide. This study aimed to assess the efficacy of a levofloxacin-amoxycillin triple therapy as a second-line treatment, and the role of primary levofloxacin resistance.

AB - First-line Helicobacter pylori therapy fails in more than 20% of patients. Quadruple therapy is the suggested second-line therapy, but bismuth salts are not anymore available worldwide. This study aimed to assess the efficacy of a levofloxacin-amoxycillin triple therapy as a second-line treatment, and the role of primary levofloxacin resistance.

KW - 2-Pyridinylmethylsulfinylbenzimidazoles

KW - Adult

KW - Amoxicillin

KW - Anti-Bacterial Agents

KW - Breath Tests

KW - Drug Resistance, Bacterial

KW - Drug Therapy, Combination

KW - Female

KW - Helicobacter Infections

KW - Humans

KW - Male

KW - Middle Aged

KW - Ofloxacin

KW - Prospective Studies

KW - Proton Pump Inhibitors

KW - Retreatment

KW - 2-Pyridinylmethylsulfinylbenzimidazoles

KW - Adult

KW - Amoxicillin

KW - Anti-Bacterial Agents

KW - Breath Tests

KW - Drug Resistance, Bacterial

KW - Drug Therapy, Combination

KW - Female

KW - Helicobacter Infections

KW - Humans

KW - Male

KW - Middle Aged

KW - Ofloxacin

KW - Prospective Studies

KW - Proton Pump Inhibitors

KW - Retreatment

UR - http://hdl.handle.net/10807/34857

U2 - 10.1016/j.dld.2007.06.016

DO - 10.1016/j.dld.2007.06.016

M3 - Article

SN - 1590-8658

VL - 39

SP - 1001

EP - 1005

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

ER -

Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo